Results 61 to 70 of about 9,895 (133)
Rapid Native and Bioprosthetic Tricuspid Valve Degeneration in Carcinoid Heart Disease
Background: Carcinoid heart disease (CaHD) is a severe complication of metastatic neuroendocrine tumors characterized by serotonin-mediated fibrotic degeneration of right-sided cardiac valves.
Lucia Trabucchi, MS +9 more
doaj +1 more source
Recurrent tricuspid regurgitation after failed ring annuloplasty is associated with high mortality rates and unfavourable clinical outcomes. Transcatheter tricuspid valve‐in‐ring (TVIR) replacement offers an alternative to high‐risk surgical reoperation,
Yiwei Wang, Yang Liu, Jian Yang
doaj +1 more source
Patient Selection for Transcatheter Tricuspid Valve Intervention: Not Too Early, Not Too Late
Tricuspid regurgitation (TR) is a common but frequently underrecognized condition associated with substantial morbidity and mortality. Long regarded as a mere bystander of left-sided heart disease, TR was often left untreated, contributing to late ...
Jennifer von Stein, MD +6 more
doaj +1 more source
The emergence of percutaneous treatment options provides novel therapeutic alternatives for older and feeble patients who are at high risk for any surgical procedure.
Nikolaos Ktenopoulos +8 more
doaj +1 more source
Transcatheter Tricuspid Valve Replacement: Current Options and Future Perspectives
Tricuspid regurgitation (TR) is a potentially lethal condition and represents a significant clinical challenge both for clinical and interventional cardiologists. Traditionally managed medically and surgically, transcatheter therapies are now an emerging
Guido Del Monaco +5 more
doaj +1 more source
A 49-year-old woman with a congenital quadricuspid aortic valve presented in cardiogenic shock due to severe aortic regurgitation. She underwent transfemoral transcatheter aortic valve replacement with a 29 mm self-expanding prosthesis. The procedure was
Abdullah Aljudaibi +2 more
doaj +1 more source
Mid-Term Outcomes and Echocardiographic Predictors of TTVR: Insights from the TRAVEL Study
Background: The mid-term prognosis after transcatheter tricuspid valve replacement (TTVR) is poorly defined, and echocardiographic predictors remain uncertain.
Xing Zhao +8 more
doaj +1 more source
Managing Bradycardia in Patients After Transcatheter Tricuspid Valve Replacement
The recent development and approval of a transcatheter tricuspid valve represent a significant breakthrough in the management of patients with tricuspid regurgitation who are not suitable for existing invasive or interventional therapies.
Andreas Hain, MD +6 more
doaj +1 more source
Early Prosthetic Thrombosis After Transcatheter Tricuspid Valve Replacement: A Word of Caution. [PDF]
Trinca F +9 more
europepmc +1 more source
Transcatheter tricuspid valve replacement-a comparison of clinical and procedural outcomes of two different prostheses. [PDF]
Genske F +6 more
europepmc +1 more source

